Arca Biopharma buy melinda
Start price
17.09.10
/
50%
€2,005.7
Target price
17.03.11
€3,402.0
Performance (%)
-27.93%
End price
17.03.11
€1,445.5
Summary
This prediction ended on 17.03.11 with a price of €1,445.5. The price of Arca Biopharma has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.93%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arca Biopharma | 6.040% | 6.040% | 64.583% | 18.797% |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
Comments by melinda for this prediction
In the thread Arca Biopharma diskutieren
Pharma
ARCA Biopharma sehr große Spezialist in der Entwicklung und Kommerzialisierung von gentechnisch-spezifischen Therapien (Herzinsuffizienz und anderen Krankheiten)
(Laufzeit überschritten)